aleeva's library 83 articles Export

	Drug and biological development : from molecule to product and beyond [My Copy] (2007) by Ronald P. Evens posted to no-tag by aleeva on 2009-08-19 19:38:00 as
	A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension--The GLANT Study. Study Group on Long-term Antihypertensive Therapy. [My Copy] Hypertension research : official journal of the Japanese Society of Hypertension, Vol. 18, No. 3. (September 1995), pp. 235-244. posted to no-tag by aleeva on 2009-08-16 08:04:44 as
	Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. [My Copy] Lancet, Vol. 354, No. 9192. (20 November 1999), pp. 1751-1756. by L. Hansson, L. H. Lindholm, T. Ekbom, et al.B. Dahlöf, J. Lanke, B. Scherstén, P. O. Wester, T. Hedner, U. de Faire posted to no-tag by aleeva on 2009-08-16 08:01:16 as
	Calcium antagonism and calcium entry blockade. [My Copy] Pharmacological reviews, Vol. 38, No. 4. (December 1986), pp. 321-416. by T. Godfraind, R. Miller, M. Wibo posted to no-tag by aleeva on 2009-08-16 07:51:56 as
	MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. [My Copy] Lancet, Vol. 360, No. 9326. (6 July 2002), pp. 7-22. by Heart Protection Study Collaborative Group posted to no-tag by aleeva on 2009-08-16 00:38:15 as along with 4 people Penquin007 nm61591 journal06 mghim
	Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy [My Copy] J. Lipid Res., Vol. 47, No. 7. (1 July 2006), pp. 1339-1351. by Daniel Steinberg posted to no-tag by aleeva on 2009-08-16 00:37:13 as along with 2 people Freefattyacids fkz1
	Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. [My Copy] Lancet, Vol. 364, No. 9438. (17 September 2004), pp. 937-952. by Salim Yusuf, Steven Hawken, Stephanie Ounpuu, et al.Tony Dans, Alvaro Avezum, Fernando Lanas, Matthew McQueen, Andrzej Budaj, Prem Pais, John Varigos, Liu Lisheng, INTERHEART Study Investigators posted to no-tag by aleeva on 2009-08-16 00:17:20 as along with 2 people sophiebostock ggrassi
	Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. [My Copy] Journal of hypertension, Vol. 16, No. 11. (November 1998), pp. 1677-1684. by E. Ambrosioni, M. Safar, J. P. Degaute, et al.P. L. Malin, M. MacMahon, D. R. Pujol, A. de Cordoüe, D. Guez posted to no-tag by aleeva on 2009-08-15 22:03:49 as
	Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. [My Copy] Hypertension, Vol. 48, No. 2. (August 2006), pp. 219-224. by Alan J. Zillich, Jay Garg, Sanjib Basu, George L. Bakris, Barry L. Carter posted to no-tag by aleeva on 2009-08-15 22:03:10 as
	Antihypertensive and biochemical effects of chlorthalidone. [My Copy] Clinical pharmacology and therapeutics, Vol. 22, No. 5 Pt 1. (November 1977), pp. 519-527. by M. G. Tweeddale, R. I. Ogilvie, J. Ruedy posted to no-tag by aleeva on 2009-08-15 22:02:23 as
	Hypokalaemia and diuretics: an analysis of publications. [My Copy] British medical journal, Vol. 280, No. 6218. (29 March 1980), pp. 905-908. by D. B. Morgan, C. Davidson posted to no-tag by aleeva on 2009-08-15 22:01:49 as
	Effects of large and small doses of hydrochlorothiazide in hypertensive patients. [My Copy] Clinical pharmacology and therapeutics, Vol. 11, No. 5. (t 1970), pp. 733-739. by P. J. McLeod, R. I. Ogilvie, J. Ruedy posted to no-tag by aleeva on 2009-08-15 21:58:13 as
	Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects. [My Copy] Blood pressure, Vol. 3, No. 4. (July 1994), pp. 231-235. by A. J. Jounela, M. Lilja, J. Lumme, et al.C. Mörlin, A. Hoyem, T. Wessel-Aas, N. J. Borrild posted to no-tag by aleeva on 2009-08-15 21:57:30 as
	The incidence of diuretic-induced hypokalemia in two distinct clinic settings. [My Copy] Journal of clinical hypertension, Vol. 2, No. 4. (December 1986), pp. 331-338. by R. L. Bloomfield, D. J. Wilson, V. M. Buckalew posted to no-tag by aleeva on 2009-08-15 21:55:46 as
	The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. [My Copy] JAMA : the journal of the American Medical Association, Vol. 289, No. 19. (21 May 2003), pp. 2560-2572. by Aram V. Chobanian, George L. Bakris, Henry R. Black, et al.William C. Cushman, Lee A. Green, Joseph L. Izzo, Daniel W. Jones, Barry J. Materson, Suzanne Oparil, Jackson T. Wright, Edward J. Roccella, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee posted to no-tag by aleeva on 2009-08-15 21:55:02 as along with 1 person R-MINI
	Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. [My Copy] JAMA : the journal of the American Medical Association, Vol. 289, No. 19. (21 May 2003), pp. 2534-2544. by Bruce M. Psaty, Thomas Lumley, Curt D. Furberg, et al.Gina Schellenbaum, Marco Pahor, Michael H. Alderman, Noel S. Weiss posted to no-tag by aleeva on 2009-08-15 21:53:45 as
	Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). [My Copy] JAMA : the journal of the American Medical Association, Vol. 288, No. 23. (18 December 2002), pp. 2981-2997. by ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial posted to no-tag by aleeva on 2009-08-15 21:52:26 as along with 3 people drftc journal06 djmonstermo
	Third generation calcium entry blockers. [My Copy] Blood pressure, Vol. 5, No. 4. (July 1996), pp. 206-208. by T. Toyo-Oka, W. G. Nayler posted to no-tag by aleeva on 2009-08-15 21:47:15 as
	Carvedilol in hypertension treatment. [My Copy] Vascular health and risk management, Vol. 4, No. 1. (2008), pp. 23-30. by Panagiotis C. Stafylas, Pantelis A. Sarafidis posted to no-tag by aleeva on 2009-08-15 21:45:47 as
	Carvedilol in the treatment of elderly patients with chronic heart failure. [My Copy] Clinical interventions in aging, Vol. 3, No. 1. (2008), pp. 55-70. by Klaus K. Witte, Andrew L. Clark posted to no-tag by aleeva on 2009-08-15 21:44:52 as
	TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. [My Copy] Nature medicine, Vol. 4, No. 4. (April 1998), pp. 415-420. by M. Sata, K. Walsh posted to no-tag by aleeva on 2009-08-15 21:43:47 as
	Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. [My Copy] Nature medicine, Vol. 4, No. 2. (February 1998), pp. 222-227. by M. J. Pollman, J. L. Hall, M. J. Mann, L. Zhang, G. H. Gibbons posted to no-tag by aleeva on 2009-08-15 21:42:20 as
	Statins and direct vascular actions. [My Copy] Panminerva medica, Vol. 45, No. 1. (March 2003), pp. 1-6. by A. O. Mueck, H. Seeger posted to no-tag by aleeva on 2009-08-15 21:41:32 as
	Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. [My Copy] Circulation, Vol. 103, No. 7. (20 February 2001), pp. 926-933. by M. Crisby, G. Nordin-Fredriksson, P. K. Shah, J. Yano, J. Zhu, J. Nilsson posted to no-tag by aleeva on 2009-08-15 21:39:51 as
	Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. [My Copy] Journal of the American College of Cardiology, Vol. 27, No. 2. (February 1996), pp. 337-344. posted to no-tag by aleeva on 2009-08-15 21:37:21 as
	Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. [My Copy] Lancet, Vol. 349, No. 9068. (21 June 1997), pp. 1787-1792. posted to no-tag by aleeva on 2009-08-15 21:32:52 as
	Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. [My Copy] The New England journal of medicine, Vol. 327, No. 10. (3 September 1992), pp. 669-677. by M. A. Pfeffer, E. Braunwald, L. A. Moyé, et al.L. Basta, E. J. Brown, T. E. Cuddy, B. R. Davis, E. M. Geltman, S. Goldman, G. C. Flaker posted to no-tag by aleeva on 2009-08-15 21:27:04 as along with 1 person djmonstermo
	Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [My Copy] Lancet, Vol. 344, No. 8934. (19 November 1994), pp. 1383-1389. posted to no-tag by aleeva on 2009-08-15 21:23:26 as along with 1 person nm61591
	Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients. [My Copy] The American journal of cardiology, Vol. 92, No. 6. (15 September 2003), pp. 670-676. by Connie B. Newman, Gary Palmer, Halit Silbershatz, Michael Szarek posted to no-tag by aleeva on 2009-08-15 21:22:16 as
	Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. [My Copy] JAMA : the journal of the American Medical Association, Vol. 295, No. 13. (5 April 2006), pp. 1556-1565. by Steven E. Nissen, Stephen J. Nicholls, Ilke Sipahi, et al.Peter Libby, Joel S. Raichlen, Christie M. Ballantyne, Jean Davignon, Raimund Erbel, Jean Charles C. Fruchart, Jean-Claude C. Tardif, Paul Schoenhagen, Tim Crowe, Valerie Cain, Kathy Wolski, Marlene Goormastic, E. Murat Tuzcu, ASTEROID Investigators posted to no-tag by aleeva on 2009-08-15 21:21:06 as along with 1 person oplm
	Cost of Treating to a Modified European Atherosclerosis Society LDL-C Target [My Copy] Clinical Drug Investigation, Vol. 17, No. 3. (1999), pp. 185-193. by D. G. Smith, S. J. Leslie, T. D. Szucs, et al.S. Mcbride, L. M. Campbell, C. Calvo, J. M. Lecerf, R. Fellin posted to no-tag by aleeva on 2009-08-15 21:18:19 as
	Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. [My Copy] Circulation, Vol. 110, No. 9. (31 August 2004), pp. 1061-1068. by Shinya Okazaki, Takayuki Yokoyama, Katsumi Miyauchi, et al.Kazunori Shimada, Takeshi Kurata, Hitoshi Sato, Hiroyuki Daida posted to no-tag by aleeva on 2009-08-15 21:10:13 as
	Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. [My Copy] JAMA : the journal of the American Medical Association, Vol. 291, No. 9. (3 March 2004), pp. 1071-1080. by Steven E. Nissen, E. Murat Tuzcu, Paul Schoenhagen, et al.B. Greg Brown, Peter Ganz, Robert A. Vogel, Tim Crowe, Gail Howard, Christopher J. Cooper, Bruce Brodie, Cindy L. Grines, Anthony N. DeMaria, REVERSAL Investigators posted to no-tag by aleeva on 2009-08-15 21:08:42 as
	Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. [My Copy] Arteriosclerosis, thrombosis, and vascular biology, Vol. 15, No. 5. (May 1995), pp. 678-682. by J. W. Nawrocki, S. R. Weiss, M. H. Davidson, et al.D. L. Sprecher, S. L. Schwartz, P. J. Lupien, P. H. Jones, H. E. Haber, D. M. Black posted to no-tag by aleeva on 2009-08-15 21:07:56 as
	Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) [My Copy] The American journal of cardiology, Vol. 81, No. 5. (1 March 1998), pp. 582-587. by P. Jones, S. Kafonek, I. Laurora, D. Hunninghake posted to no-tag by aleeva on 2009-08-15 21:06:37 as
	Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. [My Copy] Current medical research and opinion, Vol. 18, No. 4. (2002), pp. 220-228. by Vasilios G. Athyros, Athanasios A. Papageorgiou, Bodosakis R. Mercouris, et al.Valasia V. Athyrou, Athanasios N. Symeonidis, Elias O. Basayannis, Dimokritos S. Demitriadis, Athanasios G. Kontopoulos posted to no-tag by aleeva on 2009-08-15 21:05:38 as
	Depression: a major contributor to world-wide disease burden [My Copy] International Medical News, Vol. 99, No. 2. (1999), pp. 1-2. by D. Kupfer posted to no-tag by aleeva on 2009-08-15 20:59:41 as
	Size and burden of depressive disorders in Europe. [My Copy] European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, Vol. 15, No. 4. (August 2005), pp. 411-423. by Eugene S. Paykel, Traolach Brugha, Tom Fryers posted to lib by aleeva on 2009-08-15 20:52:19 as
	Personality disorders: a challenge for transplantation. [My Copy] Progress in transplantation (Aliso Viejo, Calif.), Vol. 10, No. 4. (December 2000), pp. 226-232. by F. Dobbels, C. Put, J. Vanhaecke posted to lib by aleeva on 2009-08-15 20:35:27 as
	European Cardiovascular Disease Statistics. 2005. [My Copy] (2005), 100. by S. Petersen, V. Peto, M. Rayner, J. Leal, R. Luengo-Fernandez, A. Gray posted to lib by aleeva on 2009-08-15 20:08:49 as
	Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [My Copy] Atherosclerosis Supplements, Vol. 5, No. 3. (October 2004), pp. 81-87. by T. Pedersen posted to heart-failure by aleeva on 2009-08-15 14:59:56 as along with 1 person cchand
	International multicentre study of indapamide in the treatment of essential arterial hypertension. [My Copy] Postgraduate medical journal, Vol. 57 Suppl 2 (1981), pp. 57-59. by J. Passeron, N. Pauly, J. Desprat posted to indapamide hypertension diuretics by aleeva on 2009-08-14 17:05:13 as
	Fixed Dose Combination of Perindopril and Indapamide Improves Peripheral Vascular Function in Essential Hypertensive Patients [My Copy] Am J Hypertens, Vol. 22, No. 5. (26 February 2009), pp. 506-512. by Lorenzo Ghiadoni, Armando Magagna, Isabella Kardasz, Stefano Taddei, Antonio Salvetti posted to indapamide hypertension diuretics by aleeva on 2009-08-14 07:11:29 as
	Treatment of hypertension in patients 80 years of age or older. [My Copy] The New England journal of medicine, Vol. 358, No. 18. (1 May 2008), pp. 1887-1898. by Nigel S. Beckett, Ruth Peters, Astrid E. Fletcher, et al.Jan A. Staessen, Lisheng Liu, Dan Dumitrascu, Vassil Stoyanovsky, Riitta L. Antikainen, Yuri Nikitin, Craig Anderson, Alli Belhani, Françoise Forette, Chakravarthi Rajkumar, Lutgarde Thijs, Winston Banya, Christopher J. Bulpitt, HYVET Study Group posted to indapamide hypertension diuretics by aleeva on 2009-08-14 07:07:35 as along with 2 people cardioexe guhjy
	Protective Action of Indapamide, a Thiazide-Like Diuretic, on Ischemia-Induced Injury and Barrier Dysfunction in Mouse Brain Microvascular Endothelial Cells [My Copy] Journal of Pharmacological Sciences, Vol. 103, No. 3. (2007), pp. 323-327. by Tsuyoshi Nishioku, Fuyuko Takata, Atsushi Yamauchi, et al.Noriko Sumi, Ikumi Yamamoto, Akiko Fujino, Mikihiko Naito, Takashi Tsuruo, Hideki Shuto, Yasufumi Kataoka posted to indapamide hypertension diuretics by aleeva on 2009-08-14 07:01:49 as
	Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats. [My Copy] The Journal of pharmacology and experimental therapeutics, Vol. 325, No. 3. (June 2008), pp. 766-773. by Dong You, Clément Cochain, Céline Loinard, et al.José Vilar, Barend Mees, Micheline Duriez, Bernard I. Lévy, Jean-Sébastien S. Silvestre posted to indapamide heart-failure diuretics by aleeva on 2009-08-14 06:57:36 as
	A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. [My Copy] The American journal of cardiology, Vol. 77, No. 6. (22 February 1996) by R. P. Ames posted to indapamide hypertension diuretics by aleeva on 2009-08-13 16:49:54 as
	Clinical implications of indapamide sustained release 1.5 mg in hypertension. [My Copy] Clinical pharmacokinetics, Vol. 37 Suppl 1 (1999), pp. 21-32. by R. Donnelly posted to indapamide hypertension diuretics by aleeva on 2009-08-13 16:47:45 as
	Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage. [My Copy] Journal of hypertension. Supplement : official journal of the International Society of Hypertension, Vol. 21, No. 3. (June 2003) by Stéphane Laurent posted to indapamide hypertension diuretics by aleeva on 2009-08-13 16:46:58 as
	Perindopril 2mg/indapamide 0.625mg. Fixed low-dose combination. [My Copy] Drugs, Vol. 58, No. 2. (August 1999) by K. J. McClellan, A. Markham posted to indapamide hypertension diuretics by aleeva on 2009-08-13 16:46:22 as